The presentation highlights ALG-097558 Phase 1 data showing that single (up to 2000 mg) and multiple (up to 800 mg Q12 for 7 days) doses of this potent, pan-coronavirus protease inhibitor were well ...
Within the 3 months after vaccination, 8.6% of patients had anterior uveitis, and 1.6% nonanterior uveitis. The total rates ...